ICTER’s strategic foreign partner is the Institute of Ophthalmology within the Faculty of Brain Sciences of University College London, in the United Kingdom.
About UCL
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. It is among the world’s top universities, as reflected by performance in a range of international rankings and tables. UCL currently has almost 29,000 students from 150 countries and in the region of 10,000 employees.
Source, and further information: www.ucl.ac.uk.
About UCL Institute of Ophthalmology
UCL Institute of Ophthalmology is one of the foremost eye and vision research institutes in the world. It operates at the cutting edge of translational research, delivering new therapies, diagnostic tools and preventive measures to patients suffering from visual impairment or blinding conditions. The Institute conducts research and post-graduate teaching in the area of ophthalmology (the anatomy, physiology, and diseases of the eye). The UCL-IoO is able to bring its science to life through a partnership with Moorfields Eye Hospital in UK government-sponsored NIHR- Biomedical Research Centre, elaborating its ability to undertake experimental medicine studies, early phase trials and exploit the well-curated and large population base of patients with inherited eye disease and common ophthalmic disorders. The combination of the Institute’s research resource with Moorfields Eye Hospital, which has the largest ophthalmic patient population in the western world, opens the way for further advances in vision research. Close collaboration with other academic partners and with industry extends its impact. The Institute has been named as the best place to study ophthalmology in the 2017 Centre for World University Rankings (CWUR).
Source, and further information: www.ucl.ac.uk/ioo.